"Becoming engrossed in this mindset leads to rigid thinking, hyperfixation and can have real impacts on people’s lives." ...
Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous ...
Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of ...
Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.
Sanofi and Regeneron's Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria Approval for children aged two to 11 years with ...
Detailed price information for Ascendis Pharma ADR (ASND-Q) from The Globe and Mail including charting and trades.
Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria ...
Approval for children aged 2 to 11 years with CSU who remain symptomatic despite H1 antihistamine treatment based primarily on data from the LIBERTY-CUPID clinical trial program CSU is a chronic skin ...
Morning Overview on MSN
UK team says brain-inspired chip could cut AI energy use by up to 2,000x
Physicists at Loughborough University have built a brain-inspired chip they say could slash the energy cost of certain AI ...
In a recent research note (“How reliable is the Adcorp Employment Index?”, 1 March 2012), two University of Cape Town ...
Our study is motivated by evaluating the role of hematopoietic cell transplantation (HCT) after chimeric antigen receptor T-cell (CAR-T) therapy for ALL, a debated topic. Because patients may receive ...
Rolling coverage of the latest economic and financial news, as IMF managing director Kristalina Georgieva gives a press conference in Washington DC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results